Litcius/Paper detail

AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss

Santanu Hati, Marisa Zallocchi, Robert A. Hazlitt, Yuju Li, Sarath Vijayakumar, Jaeki Min, Zoran Ranković, Sándor Lovas, Jian Zuo

2021European Journal of Medicinal Chemistry42 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryCyclin-dependent kinase 2OtotoxicityKinaseIn vivoPharmacologySmall moleculeBiochemistryCisplatinProtein kinase ABiologyInternal medicineMedicineChemotherapyBiotechnologyProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysMultiple Myeloma Research and Treatments